Background: Ultra processed food (UPF) intake has been associated with multiple negative health outcomes. Research investigating UPF intake and cognitive health outcomes has begun. The aim of this review is to summarise the existing evidence of associations between exposure to UPFs, as defined by the NOVA food classification system, and cognitive health outcomes. Methods: We conducted a systematic search across MEDLINE, PsycINFO, Embase, and APA Psych Articles through OVID, and PubMed for relevant studies up-until October 2024. The Newcastle-Ottawa Scale was used to assess the quality of included studies. A narrative approach was used to summarise and integrate results across studies. Results: Three hundred and eighty-three articles were screened and five met the inclusion criteria. All studies were published between 2022 and 2024. The association between UPF intake and four different cognitive outcomes (dementia risk, cognitive impairment risk, cognitive performance and cognitive change trajectories) were explored across the studies. Three out of the five included studies found a significant negative main effect of consuming UPF on the cognitive outcome of interest. All studies identified adverse consequences of consumption in either a sub-group of the population or a sub-group of UPF type. Conclusions: Deleterious effects of UPF consumption on multiple cognitive health outcomes were identified across all studies. However, the results suggest the relationship may be specific to sub-groups of the population or sub-groups of UPF type. Conclusions should be drawn with caution due to the limited number of studies available examining UPF intake according to NOVA and its association with cognitive outcomes, as well as the variability in cognitive measures assessed and other methodological differences across studies.

The authors have declared no competing interest.

This study was funded by Medical Research Council DPUK grant MR/To333771

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This is a systematic review that only used already published data, which has been approved by the original authors.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

All data produced in the present work are contained in the manuscript.